LOS ANGELES

洛杉矶

,

，

March 19, 2026

2026年3月19日

/PRNewswire/ -- Agilisium, a domain-native AI services company focused exclusively on Life Sciences, today announced a $5.5 million investment to transform how pharmaceutical, biotech, and medtech enterprises operationalize AI. Central to the initiative is FDX, Forward Deployment Experts — a new professional standard built across four dimensions: Domain, AI & Technology, Consultative Solutioning, and Systems & Process Thinking..

/PRNewswire/ -- Agilisium，一家专注于生命科学领域的本土AI服务公司，今天宣布投资550万美元，旨在变革制药、生物技术和医疗技术企业如何将AI投入实际应用。该计划的核心是FDX（Forward Deployment Experts，前沿部署专家）—— 一种基于四个维度构建的全新专业标准：领域知识、人工智能与技术、咨询解决方案设计以及系统与流程思维。

Unlike traditional consulting models, FDX professionals are not offsite advisors. They are embedded directly inside client organizations, working alongside scientific, regulatory, and commercial teams to design, deploy, and continuously operate AI-driven capabilities. Agilisium will transform and deploy its global workforce of more than 1,000 professionals under this model, making it the world's first forward deployment expert framework built exclusively for Life Sciences..

与传统的咨询模式不同，FDX的专业人员并非场外顾问。他们直接嵌入客户组织内部，与科学、监管和商业团队并肩工作，设计、部署并持续运作人工智能驱动的能力。Agilisium将在此模式下转型并部署其超过1000名专业人员的全球团队，成为全球首个专为生命科学领域打造的前沿部署专家框架。

The initiative addresses a critical industry gap: a shortage of AI engineers or life scientists in isolation, but of professionals who combine both alongside the regulatory fluency that Life Sciences demands. Enterprise AI initiatives continue to stall not because the technology fails, but because the talent to operationalize it does not exist at scale..

该计划旨在解决一个关键的行业缺口：并非单纯缺乏人工智能工程师或生命科学家，而是缺少同时具备两者技能并拥有生命科学领域所需监管知识的专业人士。企业的人工智能计划持续陷入停滞，并非因为技术本身失败，而是因为能够大规模将其投入运营的人才匮乏。

'The biggest constraint in AI adoption in Life Sciences is no longer technology — it is talent. The companies that will lead the next decade will be the ones that embed AI capability deep inside their organizations. At Agilisium, our advantage comes from the compounding institutional and domain knowledge we have built by focusing exclusively on Life Sciences.'.

“生命科学领域采用人工智能的最大制约因素不再是技术，而是人才。未来十年的领军企业将是那些将人工智能能力深植于组织内部的公司。在Agilisium，我们的优势来自于通过专注于生命科学领域所积累的复合型制度与领域知识。”

— Raj Babu, Founder and CEO, Agilisium

— Raj Babu，创始人兼首席执行官，Agilisium

Three Offerings. One Integrated Model.

三个产品。一个集成模型。

The forward deployment model is delivered through three integrated offerings:

前向部署模型通过三个集成的方案交付：

FDX — Forward Deployment Experts:

FDX — 前置部署专家：

Senior practitioners embedded inside client teams who rebuild scientific, regulatory, and commercial workflows with AI at their core and own outcomes end-to-end.

嵌入客户团队的资深从业者，他们以人工智能为核心重建科学、监管和商业工作流程，并端到端地对结果负责。

FDA — Forward-Deployment Agents:

FDA — 前置部署代理：

Autonomous AI agents trained on each enterprise's proprietary data, regulatory frameworks, and operational logic — not generic models adapted from the outside.

训练自主人工智能代理时，使用的是每个企业的专有数据、监管框架和运营逻辑，而不是从外部适应的通用模型。

FDS — Forward-Deployment Services:

FDS — 前置部署服务：

Managed teams that remain embedded post-deployment, continuously running and evolving AI capabilities so clients inherit a functioning, improving system — not technical debt.

管理那些在部署后仍然嵌入的团队，持续运行和进化人工智能能力，使客户继承一个功能完善、不断改进的系统，而非技术债务。

'By integrating AI, innovation, and execution, we are building an operating model that translates intelligence into real-world impact at scale. Our FDX professionals are the connective tissue between AI potential and enterprise results.'

“通过整合人工智能、创新和执行，我们正在构建一种将智能转化为大规模现实影响的运营模式。我们的FDX专业人士是人工智能潜力与企业成果之间的纽带。”

— Arunkumar Arjunan, Chief Operating Officer and Chief AI & Innovation Officer, Agilisium

——阿伦库马尔·阿尔朱南，首席运营官兼首席人工智能与创新官，Agilisium

About Agilisium

关于Agilisium

Agilisium is the leading domain-native AI services partner for the Life Sciences industry, combining deep domain expertise with Contextual Autonomous Agentic AI and Advanced Analytics. The company partners with leading pharmaceutical and biotech organizations to automate mission-critical processes and accelerate outcomes across the full value chain — from drug discovery and clinical development to regulatory operations and commercial success.

Agilisium 是生命科学领域领先的本土AI服务合作伙伴，结合了深厚的领域专业知识、情境自主代理AI以及高级分析技术。该公司与领先的制药和生物技术组织合作，自动化关键任务流程，并加速整个价值链的成果——从药物发现和临床开发到法规事务运营和商业成功。

Learn more at .

了解更多，请访问。

www.agilisium.com

www.agilisium.com

.

。

SOURCE Agilisium Consulting

来源：Agilisium 咨询公司

21

21

%

%

more press release views with

更多新闻发布视图与

Request a Demo

请求演示